ABO-Incompatible Adult Living Donor Liver Transplantation for Hepatocellular Carcinoma

Transplantation Proceedings

Volumn 40, Issue 8, 2008, Pages 2497-2500

  Matsuno, N ^a   Iwamoto, H ^a   Nakamura, Y ^a   Hama, K ^a   Kihara, Y ^a   Konno, O ^a   Jojima, Y ^a   Akashi, I ^a   Mijiti, A ^a   Ashizawa, T ^a   Nagao, T ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROSTAGLANDIN E1; RITUXIMAB; TACROLIMUS;

ACUTE HEART INFARCTION; ADULT; AGED; ARTERY THROMBOSIS; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CANCER PATIENT; CLINICAL ARTICLE; CONTINUOUS INFUSION; DRUG DOSE REDUCTION; DRUG INFUSION; HEMATOMA; HEPATIC ARTERY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CELL CARCINOMA; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; MAINTENANCE DRUG DOSE; PERFORATION; PLASMAPHERESIS; PORTAL VEIN THROMBOSIS; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SINGLE DRUG DOSE; SPLENECTOMY; TUMOR RECURRENCE;

ABO BLOOD-GROUP SYSTEM; ADULT; BLOOD GROUP INCOMPATIBILITY; CARCINOMA, HEPATOCELLULAR; DRUG THERAPY, COMBINATION; GRAFT REJECTION; HEPATITIS B; HEPATITIS C; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENTS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; MIDDLE AGED; NEOPLASM STAGING; PLASMAPHERESIS; SPLENECTOMY; SURVIVAL ANALYSIS; SURVIVORS; TREATMENT OUTCOME;

EID: 53149134684     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.07.054     Document Type: Article

References (11)

1. Demetris A.J., Jaffe R., Tzakis A., et al. Antibody-mediated rejection of human orthotopic liver allografts. A study of liver transplantation across ABO blood group barriers. Am J Pathol 132 (1988) 489
2. Gugenheim J., Samuel D., Reynes M., et al. Liver transplantation across ABO blood group barriers. Lancet 336 (1990) 519
3. Farges O., Kalil A.N., Samuel D., et al. The use of ABO-incompatible grafts in liver transplantation: a life-saving procedure in highly selected patients. Transplantation 59 (1995) 1124
4. Takahashi K. A new concept of accommodation in ABO-incompatible kidney transplantation. Clin Transplantation 19 (2005) 76
5. Tanabe K., Takahashi K., Sonda K., et al. Long-term results of ABO-incompatible living kidney transplantation: a single-center experience. Transplantation 65 (1998) 224
6. Bjoro K., Ericzon B.G., Kirkegaard P., et al. Highly urgent liver transplantation: possible impact of donor-recipient ABO matching on the outcome after transplantation. Transplantation 75 (2003) 347
7. Oike F., Kamei H., and Tanaka K. Novel approaches for ABO blood-type incompatible liver transplantation from living donor: intraportal infusion therapy and hepatic arterial infusion therapy. Konnichi No Ishoku 16 (2003) 479
8. Hanto D.W., Fecteau A.H., Alonso M.H., et al. ABO-incompatible liver transplantation with no immunological graft losses using total plasma exchange, splenectomy, and quadruple immunosuppression: evidence for accommodation. Liver Transplant 9 (2003) 22
9. Shimmura H., Tanabe K., Ishikawa N., et al. Role of anti-A/B antibody in results of ABO-incompatible kidney transplantation. Transplantation 70 (2000) 1331
10. Ishida H., Tanabe K., Toma H., et al. Therapeutic apheresis therapy for ABO-incompatible renal transplantation. Therapeutic Apheresis Dialysis 7 (2003) 520
11. Takaya S., Iwaki Y., and Starzl T.E. Liver transplantation in positive cytotoxic crossmatch case using FK506, high-dose steroids, and prostaglandin E. Transplantation 54 (1992) 927